However use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy hcm due to lack of pharmacodynamic data for pimobendan in cats with hcm and due to theoretical concerns for exacerbating left ventricular outflow tract.
Pimobendan for cats dosage.
For cats receiving pimobendan the median survival time was 626 days compared to the median survival time of 103 days for cats not receiving pimobendan.
All cats were treated with pimobendan.
Concurrent use of a beta blocker atenolol may decrease the efficacy of pimobendan standard dosage forms pimobendan chewable tablets 1 25mg 2 5mg 5mg 10mg.
Also no adverse events were reported in case versus control cats in the study.
Pimobendan vetmedin is a heart medication that is becoming a frequently used drug for cats with heart disease it is approved for use in the united states for dogs with congestive heart failure chf caused by either dilated cardiomyopathy or mitral valve disease but it is not licensed for use in cats and is considered controversial.
Another study showed pimobendan s usefulness in improving the quality of life by reducing heart.
Pimobendan was used in combination with multiple concurrent medications including angiotensin converting enzyme inhibitors diuretics and anti thrombotics.
The median pimobendan dose was 0 24 mg kg q 12 h.
Five cats 3 0 had potential side effects associated with pimobendan.
Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy.